Formulation of Monoclonal Antibody Therapies: From Lab to Market covers a wide range of topics about therapeutic monoclonal antibodies (mAbs) with a focus on formulation aspects. Therapeutic monoclonal antibodies are used for treatment of chronic diseases. It brings together a comprehensive knowledge in one accessible volume. Starting with foundational information on monoclonal antibodies, the book then discusses the importance of biopharmaceutical products, monoclonal antibodies and biosimilars in treatment of chronic diseases, pharmaceutical aspects of mAbs, and how it can be administered. It also covers the industrial point of view and the clinical application of mAbs including in oncology, general medicine, rheumatology, hematology, dermatology, gastrointestinal tract, metabolic diseases, and dentistry. Formulation of Monoclonal Antibody Therapies: From Lab to Market is essential reading for researchers in biotechnology and biopharmaceutical fields, academics and pharmaceutical industrial scientists, and university students in pharmaceutical and biopharmaceutical sciences.
1. Chapter One. Introduction about monoclonal antibodies - p. 1 2. Chapter Two. Biosimilar antibodies - p. 39 3. Chapter THREE. Pharmaceutical aspects of mAbs: formulation, characterization, and current route of administration of monoclonal antibody therapies - p. 53 4. Chapter Four. Route of monoclonal antibodies administration - p. 209 5. Chapter Five. Industrial aspects of finished monoclonal antibody therapies - p. 259 6. Chapter Six. Application of approved and marketed products of monoclonal antibody therapies - p. 287 7. Index - p. 329
Formulation of Monoclonal Antibody Therapies: From Lab to Market covers a wide range of topics about therapeutic monoclonal antibodies (mAbs) with a focus on formulation aspects. Therapeutic monoclonal antibodies are used for treatment of chronic diseases. It brings together a comprehensive knowledge in one accessible volume. Starting with foundational information on monoclonal antibodies, the book then discusses the importance of biopharmaceutical products, monoclonal antibodies and biosimilars in treatment of chronic diseases, pharmaceutical aspects of mAbs, and how it can be administered. It also covers the industrial point of view and the clinical application of mAbs including in oncology, general medicine, rheumatology, hematology, dermatology, gastrointestinal tract, metabolic diseases, and dentistry. Formulation of Monoclonal Antibody Therapies: From Lab to Market is essential reading for researchers in biotechnology and biopharmaceutical fields, academics and pharmaceutical industrial scientists, and university students in pharmaceutical and biopharmaceutical sciences.
1. Chapter One. Introduction about monoclonal antibodies - p. 1 2. Chapter Two. Biosimilar antibodies - p. 39 3. Chapter THREE. Pharmaceutical aspects of mAbs: formulation, characterization, and current route of administration of monoclonal antibody therapies - p. 53 4. Chapter Four. Route of monoclonal antibodies administration - p. 209 5. Chapter Five. Industrial aspects of finished monoclonal antibody therapies - p. 259 6. Chapter Six. Application of approved and marketed products of monoclonal antibody therapies - p. 287 7. Index - p. 329
